Skip to main content

Month: August 2020

New Found Gold Completes Initial Public Offering

NOT FOR DISTRIBUTION IN THE UNITED STATESVANCOUVER, British Columbia, Aug. 11, 2020 (GLOBE NEWSWIRE) — New Found Gold Corp. (“NFG” or the “Company”) today announced the successful closing of its initial public offering (the “Offering”) of an aggregate of 21,000,000 common shares at a price of $1.30 per share (the “Offering Price”) for total gross proceeds of $27,300,000.The common shares of the Company will commence trading today on the TSX Venture Exchange under the symbol “NFG”.Canaccord Genuity Corp. and BMO Capital Markets acted as co-lead agents for the Offering with respect to a syndicate that included Desjardins Securities Inc. (the “Agents”).NFG has granted the Agents an over-allotment option (the “Over-Allotment Option”), exercisable in whole or in part, at the sole discretion of the Agents, at any time and from time to time,...

Continue reading

ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2020

DOYLESTOWN, Pennsylvania, Aug. 11, 2020 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced net sales of $3.6 million for the three months ended June 30, 2020, compared to net sales of $1.7 million for the three months ended June 30, 2019. The Company recognized net income for the three months ended June 30, 2020 of $70,000, or $0.01 per share, compared to a net loss of $1.2 million, or ($0.11) per share, for the three months ended June 30, 2019.Results for the second quarter of 2020 compared to the second quarter of 2019 principally reflect the net effect of (i) an increase in net sales of $1.9 million due to an increase in third party customer orders, (ii) a decrease in administrative costs of $62,000 due principally to a decrease in professional fees, (iii) a decrease in sales and marketing...

Continue reading

Bots, Inc. Awarded Contract to Build Blockchain Powered Real Estate Platform for Elbrus Capital Markets, LLC.

SAN JUAN, Puerto Rico, Aug. 11, 2020 (GLOBE NEWSWIRE) — BOTS, Inc. (OTC: BTZI) (GERMAN EXCHANGE: M06.SG), an emerging innovator of products, technologies, and services for the rapidly growing digital robotic automation and manufacturing industry announced today that Elbrus Capital Markets (ECM) has awarded an exclusive $400,000 contract for the Company to develop a Real Estate industry blockchain-powered supply chain management platform. The contract is contingent on ECM receiving additional funding from accredited investors unless Bots elects to receive partial or all payments in the equity ownership of ECM. “Digital ledger technology is an integral part revolutionizing the whole process which is why we choose BOTS, Inc. to develop a streamlined process of real estate property ownership through a highly scalable blockchain-powered...

Continue reading

City of Santa Monica Renews with Conduent Transportation to Provide Curbside Management Systems and Services

Since 2004, Conduent has helped the city to deliver a convenient experience for Santa Monica residents, merchants and visitors9-year contract expands online and mobile self-help options for customers to resolve parking citations and manage parking permitsFLORHAM PARK, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — Conduent Transportation, a unit of business process services and solutions company Conduent Incorporated (Nasdaq: CNDT), today announced its selection by the City of Santa Monica, California, to continue providing intelligent parking and curbside management systems and services. The 5-year base contract, plus up to 4 years of options, will expand online and mobile self-help options for customers to manage their account.“Our partnership with Conduent has been instrumental in helping optimize our parking program and offering our...

Continue reading

Greenhouse Treatment Center’s Virtual CEU Course Explores Innovative Therapeutic Methods

GRAND PRAIRIE, Texas, Aug. 11, 2020 (GLOBE NEWSWIRE) — Greenhouse Treatment Center, a leading provider of substance use treatment services in Texas, is hosting a virtual CEU event for mental health and medical professionals on therapeutic experiential models in a presentation titled, “Expanding Your Therapeutic Horizons.” August’s CEU event will be hosted by Linda Doutre, LPC-S, LFMT-S. Attendees will earn one CEU credit.The continuing education event will take place on Friday, August 14 from noon  to 1:30 p.m. Information on attendance is below. From Doutre’s presentation, attendees will be introduced to three different therapeutic experiential models and how each one addresses anger, anxiety, trauma and impulsive behaviors.“We are very thankful to Linda for being this month’s CEU instructor,” said Tyler Harrell, CEO of Greenhouse...

Continue reading

Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

TORONTO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, US: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce, further to its press release of June 12, 2020, that under its sponsored research partnership agreement entered with the  Reed Research Group out of the University of Wisconsin-Madison to evaluate novel formulations of psilocybin, the Company has received the first set of orally dissolvable thin film strips initially to be used to deliver psilocybin and subsequently additional psychedelic-derived medicines.“We are very pleased about the progress we have achieved to date and this technical milestone for our drug delivery technology specifically in the development of...

Continue reading

I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Toxicology to Drive Growth of Expanding Toxicology Business

WEST LAFAYETTE, Ind., Aug. 11, 2020 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, announced today that I.M. (Gina) Grossi, Ph.D., has joined the Company as Vice President, Toxicology, effective August 10, 2020. Dr. Grossi joins as the Company continues to invest in people and facilities to support the growing demand for Inotiv services.Inotiv’s philosophy, “Expect More,” reflects a broadly capable, right-sized CRO with a strong commitment to client-focused service. Dr. Grossi’s track record of successfully managing a range of research activities and related financials, coupled with her background in developing and cultivating client relationships,...

Continue reading

Esports Entertainment Group Signs LOI to Acquire Assets of FLIP Sports

BIRKIRKARA, Malta, Aug. 11, 2020 (GLOBE NEWSWIRE) — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, signed a Letter of Intent (“LOI”) to acquire certain assets of FLIP Sports Limited (“FLIP”), including staff and all intellectual property.  “The FLIP team are leaders in building iGaming platforms that take the player experience to new heights,” stated John Brackens, CIO/CTO of Esports Entertainment Group. “Their expertise will strengthen our efforts in esports and help us further create a best-in-class immersive experience for esports fans.”FLIP Sports is a dynamic and entrepreneurial mobile games studio innovating how fans enjoy and engage with live sports. Through its proprietary in-play, peer-to-peer technology, FLIP...

Continue reading

RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility

ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the US Food and Drug Administration (FDA) conditionally approved the Company’s Investigational Device Exemption (IDE) application to conduct a clinical trial to evaluate the safety and feasibility of autologous stem cells rendered by its CellMist™ System from donor skin and applied topically with the SkinGun™ spray device for treatment of burn wounds.“The FDA conditional approval marks a significant milestone for RenovaCare and our technology for spraying an ultra-gentle mist of a patient’s own skin cells for the healing of burns and wounds. We are working to complete the...

Continue reading

Bespoke Extracts Chooses Buy-Now-Pay-Later Sezzle Payment Platform for CBD Ecommerce Store

SUNNY ISLES, Fla., Aug. 11, 2020 (GLOBE NEWSWIRE) — Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, hemp-derived CBD products, today announced that it has chosen Sezzle to complement its traditional credit card payment platform for its ecommerce store found at www.bespokeextracts.com. In addition, beginning in mid- to late September, the Company reported that consumers may also elect to pay for CBD products purchased from Bespoke’s online store using Bitcoin and Ether cryptocurrencies as an alternative to U.S. dollars.Sezzle is a buy-now-pay-later payment platform that offers consumers a short-term, interest-free installment plan that delivers both a budgeting and easy financing value proposition, allowing consumers to make online purchases and effectively split the payment for the purchase over four equal, interest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.